Ectopic Corticotropin-Producing Neuroendocrine Tumor of the Pancreas Treated With 177Lu DOTATATE Induction and Maintenance Peptide Receptor Radionuclide Therapy

被引：8
作者：
Makis, William [1 ]
McCann, Karey [1 ]
Riauka, Terence A. [1 ]
McEwan, Alexander J. B. [1 ]
机构：
[1] Cross Canc Inst, Dept Diagnost Imaging, 11560 Univ Ave NW, Edmonton, AB T6G 1Z2, Canada
来源：
CLINICAL NUCLEAR MEDICINE | 2016年 / 41卷 / 01期
关键词：
peptide receptor radionuclide therapy; Lu-177-DOTATATE; pancreatic neuroendocrine tumor; ectopic corticotropin; Cushing syndrome;
D O I：
10.1097/RLU.0000000000000971
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
A 57-year-old woman diagnosed with ectopic Cushing syndrome was found to have a In-111-octreotide-avid corticotropin-producing pancreatic neuroendocrine tumor with liver metastases. She was treated with 4 induction and 4 maintenance cycles of Lu-177-DOTATATE, which normalized her serum corticotropin levels and dramatically reduced the size of the pancreatic primary and liver metastases.
引用
收藏
页码：50 / 52
页数：3
相关论文
共 8 条
  • [1] Radiolabelled somatostatin analogue treatment in gastroenteropancreatic neuroendocrine tumours: factors associated with response and suggestions for therapeutic sequence
    Campana, Davide
    Capurso, Gabriele
    Partelli, Stefano
    Nori, Francesca
    Panzuto, Francesco
    Tamburrino, Domenico
    Cacciari, Giulia
    Delle Fave, Gianfranco
    Falconi, Massimo
    Tomassetti, Paola
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 (08) : 1197 - 1205
  • [2] Davi Maria Vittoria, 2008, Endocr Pract, V14, P213
  • [3] Gilis-Januszewska A, 2007, END ABSTR, V14, pP172
  • [4] Treatment with the radiolabeled somatostatin analog [177Lu-DOTA0, Tyr3] octreotate:: Toxicity, efficacy, and survival
    Kwekkeboom, Dik J.
    de Herder, Wouter W.
    Kam, Boen L.
    van Eijck, Casper H.
    van Essen, Martijn
    Kooij, Peter P.
    Feelders, Richard A.
    van Aken, Maarten O.
    Krenning, Eric P.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (13) : 2124 - 2130
  • [5] Peptide Receptor Radionuclide Therapy in Patients With Gastroenteropancreatic Neuroendocrine Tumors
    Kwekkeboom, Dik J.
    de Herder, Wouter W.
    van Eijck, Casper H. J.
    Kam, Boen L.
    van Essen, Martijn
    Teunissen, Jaap J. M.
    Krenning, Eric P.
    [J]. SEMINARS IN NUCLEAR MEDICINE, 2010, 40 (02) : 78 - 88
  • [6] Novruzov F., 2014, J NUCL MED, V55, P1960
  • [7] The Value of Somatostatin Receptor Imaging with In-111 Octreotide and/or Ga-68 DOTATATE in Localizing Ectopic ACTH Producing Tumors
    Ozkan, Zeynep Gozde
    Kuyumcu, Serkan
    Balkose, Deniz
    Ozkan, Berker
    Aksakal, Nihat
    Yilmaz, Ebru
    Sanli, Yasemin
    Turkmen, Cuneyt
    Aral, Ferihan
    Adalet, Isik
    [J]. MOLECULAR IMAGING AND RADIONUCLIDE THERAPY, 2013, 22 (02) : 49 - 55
  • [8] Usefulness of somatostatin receptor scintigraphy in patients with occult ectopic adrenocorticotropin syndrome
    Tabarin, A
    Valli, N
    Chanson, P
    Bachelot, Y
    Rohmer, V
    Bex-Bachellerie, V
    Catargi, B
    Roger, P
    Laurent, F
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (04) : 1193 - 1202
1